PMC:7652766 / 38603-38748 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1513","span":{"begin":38,"end":43},"obj":"Gene"}],"attributes":[{"id":"A1513","pred":"tao:has_database_id","subj":"1513","obj":"Gene:3439"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ry. Interestingly, the treatment with IFN-α, β, or λ during the recovery phase reduced the proliferation type II alveolar epithelial cells by act"}